Le Lézard
Classified in: Transportation, Health, Science and technology, Business
Subjects: PDT, LIC

Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH


ESTILL, S.C., April 9, 2024 /PRNewswire/ -- Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain. With a keen focus on enhancing customer offerings, Oakwood Chemical has identified EMP Biotech as the ideal partner for supplying high-quality reagents and tools.

"This partnership signifies a significant milestone for Oakwood Chemical," remarked Greg Butler, a company spokesperson. "Our extensive experience led us to recognize EMP Biotech's unparalleled expertise in providing reagents and tools that align seamlessly with our oligo synthesis solutions."

The collaboration opens doors for Oakwood Chemical to distribute EMP Biotech's extensive range of products throughout North America. From cutting-edge solvents to hazardous materials, Oakwood Chemical is committed to delivering superior quality to its customers. By leveraging its Estill, South Carolina facility, Oakwood Chemical aims to streamline distribution processes, ensuring timely access to essential materials.

"Our customers in North America will benefit immensely from this partnership," Butler added. "Reduced shipping costs and immediate access to stock materials demonstrate our commitment to providing unparalleled service and support."

Oakwood Chemical's dedication to regulatory compliance ensures seamless navigation of logistical challenges associated with distributing hazardous materials. With a robust fulfillment process centered around quality control, customers can trust Oakwood Chemical to deliver excellence every step of the way.

As part of its broader strategy, Oakwood Chemical is positioning itself as a key player in the biotechnology and pharmaceutical sectors. Through collaborations like this one with EMP Biotech, Oakwood Chemical seeks to drive innovation and meet its customers' evolving needs.

Looking ahead, Oakwood Chemical and EMP Biotech anticipate further collaboration beyond the distribution of oligo-synthesis solvents and reagents. While details remain undisclosed, both parties are committed to exploring avenues for continued growth and partnership.

To support and promote EMP Biotech's products, Oakwood Chemical has integrated them into its online catalog and databases, such as Chemcats. Customers can now easily access a comprehensive range of products backed by Oakwood Chemical's unwavering commitment to quality and customer satisfaction.

For inquiries or to explore Oakwood Chemical's extensive product offerings, visit their website at https://oakwoodchemical.com, or contact them directly at (800) 467-3386.

This partnership marks the beginning of an exciting journey for Oakwood Chemical and EMP Biotech GmbH, poised to redefine standards and drive innovation in oligo synthesis.

Contact
Oakwood Chemical
https://oakwoodchemical.com   
730 Columbia Hwy. North
Estill, SC 29918
(800) 467-3386

SOURCE Oakwood Chemical


These press releases may also interest you

at 09:43
Vitrolife AB (publ) today signed an agreement to acquire 100% of the shares in eFertility (STB Zorg B.V.). This acquisition is a key element of the Vitrolife Group's strategy to bring increased standardisation and digitalisation to IVF clinics around...

at 09:41
Sign in Solutions, a leading global provider of cloud-based visitor management solutions, today announced the completion of its take-private acquisition of SmartSpace Software PLC. Previously listed on the AIM market of the London Stock Exchange,...

at 09:40
Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has successfully completed 11 installs of its eProtein Discoverytm system, including at leading...

at 09:40
AMRA Medical - a health informatics and precision medicine company that is pioneering body composition research through gold-standard MRI-based analysis platforms - collaborated on a study driven by University of Texas Southwestern and University...

at 09:35
Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery announces that all resolutions proposed at its Annual General Meeting held today were...

at 09:35
Netradyne, Inc., an industry-leading full-service video telematics and SaaS provider of artificial intelligence (AI) and edge computing safety solutions focused on driver coaching for commercial fleets, was named the winner of a Gold Stevie® Award in...



News published on and distributed by: